ज्यादा पढ़ी गई:
Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2024 inter alia to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30 2024.The trading window for dealing in securities of the Company by the Designated Persons and their immediate relatives has been already closed from October 01 2024 as communicated earlier vide our letter No. EPL/CS/SE/0014/2024 dated September 26 2024 and shall remain closed till 48 hours after the declaration of the financial results i.e. till November 09 2024 in terms of the Companys Code of Conduct for regulating monitoring and reporting of insider trading in the securities of the Company framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended.
हाल में देखा गया
सब क्लियर करें
